A year-end review of some of the new cancer treatments, exciting breakthroughs, and insights into cancer's development that emerged...
On Friday, Margaret Foti, PhD, MD (hc), chief executive officer of the American Association for Cancer Research, was honored...
In the midst of Breast Cancer Awareness Month, the US. Food and Drug Administration (FDA) provided good news for...
Breast cancer is the most commonly diagnosed cancer in the United States. In 2018, 266,120 women and 2,550 men...
In a study published in the AACR’s journal Clinical Cancer Research, a team of scientists from the University of...
The 30th Anniversary AACR Special Conference Convergence: Artificial Intelligence, Big Data, and Prediction in Cancer is focusing on a...
On Sunday, Margaret Foti, PhD, MD (hc), chief executive officer of the AACR, met with the president of Israel,...
Last week saw a flurry of new anticancer therapeutics approved by the U.S. Food and Drug Administration (FDA) for...
Acute lymphoblastic leukemia (ALL) is an aggressive cancer of the bone marrow and the blood that develops in either...
On Monday, James P. Allison, PhD, a Fellow of the AACR Academy and a past member of the AACR’s...
Editor’s note: Progress and Promise Against Cancer is the AACR’s initiative to educate the public about cancer and cancer...